| Absorption |
| Blood-Brain Barrier | BBB- | 0.9705 |
| Human Intestinal Absorption | HIA+ | 0.9936 |
| Caco-2 Permeability | Caco2- | 0.6775 |
| P-glycoprotein Substrate | Substrate | 0.5776 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9039 |
| Non-inhibitor | 0.9709 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8983 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8131 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7778 |
| CYP450 2D6 Substrate | Non-substrate | 0.6679 |
| CYP450 3A4 Substrate | Non-substrate | 0.6939 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6221 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9558 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9484 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9556 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9318 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9576 |
| Non-inhibitor | 0.8045 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Non-carcinogens | 0.9182 |
| Fish Toxicity | High FHMT | 0.8391 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9268 |
| Honey Bee Toxicity | Low HBT | 0.5673 |
| Biodegradation | Not ready biodegradable | 0.8925 |
| Acute Oral Toxicity | II | 0.7502 |
| Carcinogenicity (Three-class) | Non-required | 0.6550 |